Humanized Mouse and Rat Model Market

A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.

Humanized Mouse and Rat Model Market contains market size and forecasts of Humanized Mouse and Rat Model in global, including the following market information:

• Global Humanized Mouse and Rat Model Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Humanized Mouse and Rat Model Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Humanized Mouse and Rat Model companies in 2021 (%)

The global Humanized Mouse and Rat Model market was valued at 113.4 million in 2021 and is projected to reach US$ 181.5 million by 2028, at a CAGR of 6.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Genetic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Humanized Mouse and Rat Model include The Jackson Laboratory (US), Taconic Biosciences (US), Horizon Discovery Group(UK), genOway (France), Charles River Laboratories (US), Harbour Antibodies BV (China), Hera BioLabs (US), Vitalstar Biotechnology Co (China) and inGenious Targeting Laboratory (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Humanized Mouse and Rat Model manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Humanized Mouse and Rat Model Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Humanized Mouse and Rat Model Market Segment Percentages, by Type, 2021 (%)

• Genetic
• Cell-Based

Global Humanized Mouse and Rat Model Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Humanized Mouse and Rat Model Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical
• Biotechnology Companies
• CRO

Global Humanized Mouse and Rat Model Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Humanized Mouse and Rat Model Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Humanized Mouse and Rat Model revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Humanized Mouse and Rat Model revenues share in global market, 2021 (%)
• Key companies Humanized Mouse and Rat Model sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Humanized Mouse and Rat Model sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• The Jackson Laboratory (US)
• Taconic Biosciences (US)
• Horizon Discovery Group(UK)
• genOway (France)
• Charles River Laboratories (US)
• Harbour Antibodies BV (China)
• Hera BioLabs (US)
• Vitalstar Biotechnology Co (China)
• inGenious Targeting Laboratory (US)
• AXENIS(France)
• Crown Bioscience (US)
• Transgenic (Japan)
• Champions Oncology (US)
• Horizon Discovery Group(UK)
• Hera BioLabs (US)
• Yecuris Corporation (US)